Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group.
Journal: Expert review of endocrinology & metabolism
Published: November 27, 2025
RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases.
Journal: Cell reports. Medicine
Published: September 18, 2025
Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 09, 2025
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.
Journal: Journal of bone oncology
Published: April 09, 2025
Concerns about the paper, "Benefits of targeted vibration for bone strength and bone density in postmenopausal women with osteopenia: a randomized, sham-controlled trial".
Journal: JBMR plus
Published: September 06, 2024
Approach to determining etiology of hypophosphatemia in a patient with coexisting phosphaturic mesenchymal tumor and fibrous dysplasia.
Journal: JBMR plus
Published: June 19, 2024
Effect of Age at Time of Irradiation, Sex, Genetic Diversity, and Granulopoietic Cytokine Radiomitigation on Lifespan and Lymphoma Development in Murine H-ARS Survivors.
Journal: Radiation research
Published: February 16, 2024
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice.
Journal: Science translational medicine
Published: September 27, 2023
Last Updated: 09/26/2026